ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,494, issued on Feb. 18, was assigned to HEALTH HOPE PHARMA Ltd. (Hong Kong).
"Polymorphisms of HM30181 mesylate" was invented by Sameer Urgaonkar (Williamsville, N.Y.), Michael P. Smolinski (Amherst, N.Y.) and Johnson Yiu-Nam Lau (Houston).
According to the abstract* released by the U.S. Patent & Trademark Office: "HM30181 (shown below) can be used to improve absorption of cancer chemotherapy drugs, such as paclitaxel. Herein are described various polymorphisms of HM30181, in particular polymorphisms B, D, E, F, G, H, I, J, K, L, and M as well as their physical properties and methods for their preparation and characterization."
The patent was filed on April 19, 2023, under Appli...